ISN 9.09% 6.0¢ isonea limited

7 chronic disease management apps , page-2

  1. 10,843 Posts.
    lightbulb Created with Sketch. 4
    Great to see ISN getting some recognition for their app. Biotechs are going to do very well out of the coming boom in Australia.

    They are carving their name as the go to asthma company.

    Looking forward to the inevitable rerating to 10c
 
watchlist Created with Sketch. Add ISN (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.